# DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics

> **NCT02288676** · — · RECRUITING · sponsor: **McGill University** · enrollment: 1200 (estimated)

## Conditions studied

- Ovarian Neoplasms
- Endometrial Neoplasms
- Endometrial Cancer
- Ovarian Cancer
- Screening
- Safety
- Reduced Mortality
- Reduced Morbidity
- Early Diagnosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02288676
- **Lead sponsor:** McGill University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2014-01
- **Primary completion:** 2025-10
- **Final completion:** 2026-10
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2025-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02288676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02288676, "DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02288676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*